|
|
|
|
|
| Pharmacokinetics and Residues of Cefquinome in Milk of Lactating Chinese Dairy Cows After Intramammary Administration |
| LI Ya-fei, WANG Lin, GU Xiao-yan, ZENG Zhen-ling, HE Li-min, YANG Fan, YUAN Bo, SHU Jianhua , DING Huan-zhong |
| Laboratory of Veterinary Pharmacology, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, P.R.China |
|
|
|
摘要 The purpose of the study was to investigate the pharmacokinetics of cefquinome in plasma and milk samples of lactating Chinese Holstein following a single intramammary administration into one quarter at the dose of 75 mg. Residue depletion of cefquinome in milk administrated at one quarter following three consecutive infusions at the same dose were also carried out. Cefquinome concentrations in plasma and milk were determined by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method. A non-compartmental analysis was used to obtain the pharmacokinetic parameters of cefquinome. Following the single treatment, cefquinome wasn’t detected in any of the plasma samples. The concentration of cefquinome in milk reached peaked values (Cmax) of (599.00±322.00) μg mL-1 at 2 h after administration (Tmax), elimination half-life (t1/2λz) was (4.63±0.26) h, area under the concentration-time curve (AUC0-∞) was (4 890.19±1 906.98) μg mL-1 h, and mean residence time (MRT) was (6.03±2.27) h. In residue depletion study, cefquinome concentrations in 5 out of 6 milk samples at 72 h were lower than the maximum residue limit fixed by the European regulatory agency (20 μg kg-1 for cefquinome) and cefquinome still could be detected in milk of treated quarters at 120 h post-treatment. The maximum concentration (Cmax) of cefquinome in milk from treated quarters was (486.50±262.92) μg mL-1 and arrived at 6 h after administration (Tmax), elimination half-life (t1/2λz) was (6.30±0.76) h, area under the concentration-time curve (AUC0-∞) was (44747.79±11434.43) μg mL-1 h, and mean residence time (MRT) was (10.09±1.40) h. This study showed that cefquinome has the feature of poor penetration into blood and was eliminated quickly from milk in lactating cows after intramammary administration.
Abstract The purpose of the study was to investigate the pharmacokinetics of cefquinome in plasma and milk samples of lactating Chinese Holstein following a single intramammary administration into one quarter at the dose of 75 mg. Residue depletion of cefquinome in milk administrated at one quarter following three consecutive infusions at the same dose were also carried out. Cefquinome concentrations in plasma and milk were determined by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method. A non-compartmental analysis was used to obtain the pharmacokinetic parameters of cefquinome. Following the single treatment, cefquinome wasn’t detected in any of the plasma samples. The concentration of cefquinome in milk reached peaked values (Cmax) of (599.00±322.00) μg mL-1 at 2 h after administration (Tmax), elimination half-life (t1/2λz) was (4.63±0.26) h, area under the concentration-time curve (AUC0-∞) was (4 890.19±1 906.98) μg mL-1 h, and mean residence time (MRT) was (6.03±2.27) h. In residue depletion study, cefquinome concentrations in 5 out of 6 milk samples at 72 h were lower than the maximum residue limit fixed by the European regulatory agency (20 μg kg-1 for cefquinome) and cefquinome still could be detected in milk of treated quarters at 120 h post-treatment. The maximum concentration (Cmax) of cefquinome in milk from treated quarters was (486.50±262.92) μg mL-1 and arrived at 6 h after administration (Tmax), elimination half-life (t1/2λz) was (6.30±0.76) h, area under the concentration-time curve (AUC0-∞) was (44747.79±11434.43) μg mL-1 h, and mean residence time (MRT) was (10.09±1.40) h. This study showed that cefquinome has the feature of poor penetration into blood and was eliminated quickly from milk in lactating cows after intramammary administration.
|
|
Received: 10 December 2013
Accepted:
|
| Fund: This study was supported financially by the National Natural Science Foundation of China (31172366). |
|
Corresponding Authors:
DING Huan-zhong, Tel: +86-20-85280665, E-mail: hzding@scau.edu.cn
E-mail: hzding@scau.edu.cn
|
| About author: LI Ya-fei, E-mail: yafei.lee@163.com |
Cite this article:
LI Ya-fei, WANG Lin, GU Xiao-yan, ZENG Zhen-ling, HE Li-min, YANG Fan, YUAN Bo, SHU Jianhua , DING Huan-zhong.
2014.
Pharmacokinetics and Residues of Cefquinome in Milk of Lactating Chinese Dairy Cows After Intramammary Administration. Journal of Integrative Agriculture, 13(12): 2750-2757.
|
| Al-Taher A. 2010. Pharmacokinetics of cefquinome in camels.Journal of Animal and Veterinary Advances, 9, 848-852Bajwa N, Bansal B, Srivastava A, Ranjan R 2007.Pharmacokinetic profile of erythromycin afterintramammary administration in lactating dairy cows withspecific mastitis. Veterinary Research Communications,31, 603-610Becker M, Zittlau E, Petz M 2004. Residue analysis of15 penicillins and cephalosporins in bovine muscle,kidney and milk by liquid chromatography-tandem massspectrometry. Analytica Chimica Acta, 520, 19-32Bradley A, Breen J, Payne B, Green M. 2011. A comparisonof broad-spectrum and narrow-spectrum dry cow therapyused alone and in combination with a teat sealant. Journalof Dairy Science, 94, 692-704 Bradley A, Green M. 2009. Factors affecting cure whentreating bovine clinical mastitis with cephalosporin-basedintramammary preparations. Journal of Dairy Science, 92,1941-1953CVMP (Committee for Veterinary Medicinal Products).1995. Cefquinome. Summary Report. EMEA/MRL/005/95.European Agency for the Evaluation of MedicinalProducts, London, UK.CVMP (Committee for Veterinary Medicinal Products). 2003.Cefquinome (Extension to Horses). Summary Report (3).EMEA/MRL/883/03-FINAL. European Agency for theEvaluation of Medicinal Products, London, UK.Chin N X, Gu J W, Fang W, Neu H C. 1992. In vitro activityof cefquinome, a new cephalosporin, compared with othercephalosporin antibiotics. Diagnostic Microbiology andInfectious Disease, 15, 331-337Ehinger A, Schmidt H, Kietzmann M. 2006. Tissue distributionof cefquinome after intramammary and “systemic”administration in the isolated perfused bovine udder. TheVeterinary Journal, 172, 147-153FDA (Food and Drug Administration). 2008. CVM Updates,Cephalosporin Order of Prohibition Questions andAnswers. July 16, 2008. US Food and Drug Administration,Washington, D.C.Gehring R, Smith G W. 2006. An overview of factors affectingthe disposition of intramammary preparations used to treatbovine mastitis. Journal of Veterinary Pharmacology andTherapeutics, 29, 237-241Guerin-Faublee V, Carret G, Houffschmitt P. 2003. In vitroactivity of 10 antimicrobial agents against bacteria isolatedfrom cows with clinical mastitis. Veterinary Record, 152,466-471Hwang Y H, Song I B, Lee H K, Kim T W, Kim M S,Lim J H, Park B K, Yun H I. 2011. Pharmacokineticsand bioavailability of cefquinome in rabbits followingintravenous and intramuscular administration. Journal ofVeterinary Pharmacology and Therapeutics, 34, 618-620Kasravi R, Bolourchi M, Farzaneh N, Seifi H A, BarinA, Hovareshti P, Gharagozlou F. 2011. Efficacy ofconventional and extended intra-mammary treatment ofpersistent sub-clinical mastitis with cefquinome in lactatingdairy cows. Tropical Animal Health and Production, 43,1203-1210Li X B, Wu W X, Su D, Wang Z J, Jiang H Y, Shen J Z. 2008.Pharmacokinetics and bioavailability of cefquinome inhealthy piglets. Journal of Veterinary Pharmacology andTherapeutics, 31, 523-527Limbert M, Isert D, Klesel N, Markus A, Seeger K, Seibert G,Schrinner E. 1991. Antibacterial activities in vitro and invivo and pharmacokinetics of cefquinome (HR 111V), anew broad-spectrum cephalosporin. Antimicrobial Agentsand Chemotherapy, 35, 14-19Liu B, Zhang C, Zhang X, Yang S, Yu J, Sun J, Liu Y. 2012.Pharmacokinetics and bioavailability of cefquinome incrossbred wild boars. Journal of Veterinary Pharmacologyand Therapeutics, 35, 611-614Maes A, Meyns T, Sustronck B, Maes D, De Backer P, CroubelsS. 2007. Determination of cefquinome in pig plasma andbronchoalveolar lavage fluid by high-performance liquidchromatography combined with electrospray ionizationmass spectrometry. Journal of Mass Spectrometry, 42,657-663Prescott J F. 2006. Beta-lactam antibiotics: Cephalosporins. In:Giguere S, Prescott J F, Baggot J D, Walker R D, DowlingP M, eds., Antimicrobial Therapy in Veterinary Medicine.4th ed. Blackwell Publishing, Ames, IA. pp. 139-157Samanidou V, Nisyriou S. 2008. Multi-residue methods forconfirmatory determination of antibiotics in milk. Journalof Separation Science, 31, 2068-2090Schmid P, Thomas V. 2002. Cefquinome - Eight yearsantimicrobial susceptibility surveillance in cattle. In: XXIIWorld Buiatrics Congress. p. 147.Shpigel N, Levin D, Winkler M, Saran A, Ziv G, Böttner A.1997. Efficacy of cefquinome for treatment of cows withmastitis experimentally induced using Escherichia coli.Journal of Dairy Science, 80, 318-323Stockler R, Morin D, Lantz R, Hurley W, Constable P. 2009.Effect of milk fraction on concentrations of cephapirin anddesacetylcephapirin in bovine milk after intramammaryinfusion of cephapirin sodium. Journal of VeterinaryPharmacology and Therapeutics, 32, 345-352Suhren G, Knappstein K. 2003. Detection of cefquinome inmilk by liquid chromatography and screening methods.Analytica Chimica Acta, 483, 363-372Tenhagen B A, Köster G, Wallmann J, Heuwieser W. 2006.Prevalence of mastitis pathogens and their resistanceagainst antimicrobial agents in dairy cows in Brandenburg,Germany. Journal of Dairy Science, 89, 2542-2551Thal J, Steffen M, Meier B, Schneider E, Adriany A, UsleberE. 2011. Development of an enzyme immunoassay forthe antibiotic cefquinome and its application for residuedetermination in cow’s milk after therapeutical mastitistreatment. Analytical and Bioanalytical Chemistry, 399,1051-1059Thomas E, Roy O, Skowronski V, Zschiesche E, Martin G,Bottner A. 2004. Comparative field efficacy study betweencefquinome and gentamicin in neonatal calves with clinicalsigns of septicaemia. Revue de Médecine Vétérinaire, 155,489-493Thomas E, Thomas V, Wilhelm C. 2006. Antibacterialactivity of cefquinome against equine bacterial pathogens.Veterinary Microbiology, 115, 140-147Tohamy M A. 2011. Age-related intramuscularpharmacokinetics of cefquinome in sheep. Small RuminantResearch, 99, 72-76Uney K, Altan F, Elmas M. 2011. Development and validationof a high-performance liquid chromatography methodfor determination of cefquinome concentrations in sheepplasma and its application to pharmacokinetic studies.Antimicrobial Agents and Chemotherapy, 55, 854-859Wen H, Pan B, Wang Y, Wang F, Yang Z, Wang M. 2010.Plasma and milk kinetics of eprinomectin following topical or oral administration to lactating Chinese Holstein cows.Veterinary Parasitology, 174, 72-76Widmer A, Kummer M, Eser M W, Fürst A. 2009. Comparisonof the clinical efficacy of cefquinome with the combinationof penicillin G and gentamicin in equine patients. EquineVeterinary Education, 21, 430-435Xie W, Zhang X, Wang T, Du S. 2013. Pharmacokineticanalysis of cefquinome in healthy chickens. British PoultryScience, 54, 81-86.Yuan L, Sun J, Wang R, Sun L, Zhu L, Luo X, Fang B, Liu Y.2011. Pharmacokinetics and bioavailability of cefquinomein healthy ducks. American Journal of VeterinaryResearch, 72, 122-126Zhai S, Liu J, Wu Y, Ye J. 2007. Predicting urinary nitrogenexcretion by milk urea nitrogen in lactating ChineseHolstein cows. Animal Science Journal, 78, 395-399Zonca A, Gallo M, Locatelli C, Carli S, Moroni P, Villa R,Cagnardi P. 2011. Cefquinome sulfate behavior afterintramammary administration in healthy and infected cows.Journal of Dairy Science, 94, 3455-3461 |
| No Suggested Reading articles found! |
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
